Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : InvestRight - Short Term Trading St -- Ignore unavailable to you. Want to Upgrade?

To: Jeffrey L. Henken who wrote (140)	9/13/1998 10:24:00 PM
From: rebecca	Read Replies (3) \| Respond to of 939

Well this upcoming week certainly continues to present itself as "Tums for the Long Term" . Regarding biotechs, it is certainly clear that a rally has began in the 2nd and 3rd tier biotechs such as cnto, bgen , sepr and medi. EXIT and RGEN may appear promising. Yet, they are years away from data with significant results or FDA approval. Such thinly traded issues with no analyst coverage can be diced far below their 52 week lows with the current flight to safety mentality. Personally I feel these type of stocks offer too high of a risk reward ratio for this environment. I think there is still leverage and safer plays in the third tier companies mentioned above. Jeff, any technical assessements on any of these issues?? Rebecca